Trial Profile
The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- Acronyms LIRABONE
- 03 Sep 2018 Status changed from recruiting to completed.
- 27 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Jan 2019.
- 27 Oct 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Jan 2018.